ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
IMPAX LABORATORIES, Inc.
(NQ:
IPXL
)
18.42
USD
-0.22 (-1.18%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about IMPAX LABORATORIES, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
UPDATE 1-FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise...
Read More
category
companyNews
from
Reuters: Company News
FDA allows generic forms of Endo Health's Opana ER painkiller
May 10, 2013
May 10 (Reuters) - The U.S. Food and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise...
Read More
category
companyNews
from
Reuters: Company News
Impax Labs (IPXL), Zogenix (ZGNX) Rise as FDA Won't Block Generic Opana (ENDP)
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8327739 for the full story.
Read More
from
StreetInsider.com News Articles
Insiders Bullish on Certain Holdings of XPH
May 03, 2013
A look at the weighted underlying holdings of the SPDR S&P Pharmaceuticals ETF (XPH) shows an impressive 12.1% of holdings on a weighted basis have experienced insider buying within the past six...
Read More
category
ETFs
from
ETF Channel
UPDATE 1-Shire cuts sales forecast as some drugs miss Q1 targets
May 02, 2013
LONDON, May 2 (Reuters) - Pharmaceutical firm Shire managed to squeeze out a first-quarter earnings beat on Thursday thanks to cost controls after sales of some of its drugs, notably rare disease...
Read More
category
companyNews
from
Reuters: Company News
Shire delivers Q1 earnings beat on strong product sales
May 02, 2013
LONDON, May 2 (Reuters) - British pharmaceutical firm Shire beat expectations with a 10 percent rise in first-quarter earnings on Thursday after a strong performance from its drugs that treat...
Read More
category
companyNews
from
Reuters: Company News
Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 16c
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8295713 for the full story.
Read More
from
StreetInsider.com News Articles
Trading Radar for 05/01: Facebook (FB), Clorox (CLX), MasterCard (MA), Chesapeake (CHK), Time Warner (TWX), Sands (LVS) Report
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8291891 for the full story.
Read More
from
StreetInsider.com News Articles
Impax Laboratories Has Returned 28.6% Since SmarTrend Recommendation (IPXL)
April 30, 2013
from
Comtex SmarTrend® News Briefs
Impax (IPXL), Glaxo (GSK) Terminate Ex. U.S., Taiwan IPX066 Collaboration
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284469 for the full story.
Read More
from
StreetInsider.com News Articles
Impax Laboratories Has Returned 29.5% Since SmarTrend Recommendation (IPXL)
April 23, 2013
from
Comtex SmarTrend® News Briefs
Impax Laboratories Down 34.4% Since SmarTrend Downtrend Call (IPXL)
April 15, 2013
from
Comtex SmarTrend® News Briefs
34.4% Return Seen to Date on SmarTrend Impax Laboratories Call (IPXL)
April 08, 2013
from
Comtex SmarTrend® News Briefs
Impax Laboratories Has Returned 34.4% Since SmarTrend Recommendation (IPXL)
April 08, 2013
from
Comtex SmarTrend® News Briefs
Impax Laboratories Shares Down 37.5% Since SmarTrend's Sell Call (IPXL)
April 01, 2013
from
Comtex SmarTrend® News Briefs
15.7% of XPH Holdings Seeing Recent Insider Buys
March 22, 2013
A look at the weighted underlying holdings of the SPDR S&P Pharmaceuticals ETF (XPH) shows an impressive 15.7% of holdings on a weighted basis have experienced insider buying within the past six...
Read More
category
ETFs
from
ETF Channel
Impax Laboratories Has Returned 36.2% Since SmarTrend Recommendation (IPXL)
March 15, 2013
from
Comtex SmarTrend® News Briefs
Bargain Hunters Take Note: Insider Cluster-Buying At IPXL
March 15, 2013
A particularly strong insider buying signal is what we call a "cluster-buy" where three or more different insiders make open market purchases within a short period of one another. At Impax Laboratories...
Read More
category
Stocks
from
Market News Video
Top Buys by Top Brass: CEO Hsu's $118.1K Bet on IPXL
March 15, 2013
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider...
Read More
category
Stocks
from
Market News Video
Impax Pharmaceuticals (IPXL) to Present RYTARYTM (IPX066) Phase III Data on Monday
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8187722 for the full story.
Read More
from
StreetInsider.com News Articles
Impax Laboratories Down 34.4% Since SmarTrend Downtrend Call (IPXL)
March 08, 2013
from
Comtex SmarTrend® News Briefs
Mid-Afternoon Market Update: Dow Looks Set to Close at All-Time High, Millennial Media Stumbles
March 05, 2013
Toward the end of trading trading Tuesday, the Dow traded up 1.02 percent to 14,272.60 while the NASDAQ rose 1.34 percent to 3,224.85. The S&P also rose, gaining 1.06 percent to 1,541.09. Top Headline...
Read More
category
Earnings
,
SNTS
,
Benzinga
, and 16 more.
from
Latest Articles from Benzinga.com
Market Wrap for Tuesday, March 5: Stocks Rally as Dow Closes at New All-Time High
March 05, 2013
The U.S. stock market rallied on Tuesday, sending the Dow Jones Industrial Average out at a new all-time high. Sentiment benefited from a better than expected ISM Services Index reading and a slightly...
Read More
category
Earnings
,
SNTS
,
Management
, and 32 more.
from
Latest Articles from Benzinga.com
Unusual 11 Mid-Day Movers 03/05: (ACUR) (HIMX) (MTG) Higher; (IPXL) (DRWI) (REGI) Lower
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8157298 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Bank of America Cuts PO to $17 on Impax Laboratories on Persisting FDA Issues
March 05, 2013
Bank of America maintained Impax Laboratories (NASDAQ: IPXL ) with an Underperform rating and lowered the price objective from $20.00 to $17.00. Bank of America noted, "IPXL announced that an FDA...
Read More
category
IPXL
,
Benzinga
,
Bank of America
, and 3 more.
from
Latest Articles from Benzinga.com
Market Close: Today's Big Winners & Losers (ACUR, MTG, HIMX, DYAX, ZOLT, RNIN, IPXL, REGI, HGSH, STRN)
March 05, 2013
DailyFinance.com : Here are today's five biggest gaining stocks at closing: Acura Pharmaceuticals Inc. (NASDAQ: ACUR) is up 48.3% at $3.04. MGIC Investment Corp. (NYSE: MTG) is up 27.8% at $5.34 (new...
Read More
category
himx
,
acur
,
strn
, and 7 more.
from
DailyFinance.com
Impax Laboratories Declining With Trend-Confirming Volume (IPXL)
March 05, 2013
from
Comtex SmarTrend® News Briefs
FDA Finds More Problems At Impax Plant
March 05, 2013
The Food and Drug Administration identified additional problems at Impax Laboratories Inc.'s (Nasdaq: IPXL) Hayward manufacturing plant sending the stock price plummeting $5.01 to $14.99....
Read More
from
MarketMinute.com Stock News
Notable Analyst Rating Changes 03/05: (MTG) (APOL) (YHOO) Upgraded; (WPZ) (AAPL) (IPXL) Downgraded
March 05, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8156605 for the full story.
Read More
from
StreetInsider.com News Articles
Stocks Hitting 52-Week Lows
March 05, 2013
The Fresh Market (NASDAQ: TFM ) shares touched a new 52-week low of $41.91. Fresh Market is expected to report its Q4 earnings on March 6, 2013. Multi-Fineline Electronix (NASDAQ: MFLX ) shares reached...
Read More
category
DRWI
,
Benzinga
,
52/Week Lows
, and 7 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The Top 5 Spookiest Technologies
Nick Shchetko
2
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
5
BlackBerry: Why Expanding BBM to iOS and Android Is Smart -- and Hazardous
Sterling Wong
See All Articles
»
Financial Product Guide